» Articles » PMID: 7726316

Examining the Validity of DSM-III-R Schizoaffective Disorder and Its Putative Subtypes in the Roscommon Family Study

Overview
Journal Am J Psychiatry
Specialty Psychiatry
Date 1995 May 1
PMID 7726316
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The authors sought to assess whether the DSM-III-R category of schizoaffective disorder differs meaningfully from schizophrenia and affective illness in clinical features, outcome, and familial psychopathology. In addition, the authors evaluated the validity of two proposed subtyping systems for schizoaffective disorder: 1) bipolar versus depressive (based on presence or absence of a full manic syndrome in the past) and 2) good versus poor interepisode recovery.

Method: In the epidemiologically based Roscommon Family Study, index probands with diagnoses of schizophrenia or affective illness were selected from a case registry. Personal interviews were conducted with 88% of traceable, living probands and 86% of traceable, living first-degree relatives.

Results: Probands with schizoaffective disorder differed significantly from both those with schizophrenia and those with affective illness on lifetime psychotic symptoms as well as on outcome and negative symptoms assessed as follow-up. Relatives of probands with schizoaffective disorder had significantly higher rates of affective illness than relatives of schizophrenic probands and significantly higher rates of schizophrenia than relatives of probands with affective illness. Probands with bipolar and depressive schizoaffective disorder did not differ substantially with respect to psychotic symptoms, negative symptoms, outcome, or family history. Schizoaffective disorder probands with good interepisode recovery had fewer negative symptoms and a better outcome than those with poor recovery, but there were no significant differences in family history. Both the epidemiologic and family data are consistent with the hypothesis that schizoaffective disorder results from the co-occurrence of a high liability to both schizophrenia and affective illness.

Conclusions: On the basis of the validators examined, DSM-III-R criteria for schizoaffective disorder define a syndrome that differs meaningfully from both schizophrenia and affective illness. The division of schizoaffective disorder into bipolar and depressive subtypes was, however, not validated. The separation of schizoaffective disorder into subtypes based on level of interepisode recovery defined subtypes that differed clinically but not with respect to familial psychopathology.

Citing Articles

Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders.

Kampe A, Suvisaari J, Lahteenvuo M, Singh T, Ahola-Olli A, Urpa L Mol Psychiatry. 2024; 29(9):2733-2741.

PMID: 38556557 PMC: 11420086. DOI: 10.1038/s41380-024-02516-6.


Family Genetic Risk Scores and the Genetic Architecture of Major Affective and Psychotic Disorders in a Swedish National Sample.

Kendler K, Ohlsson H, Sundquist J, Sundquist K JAMA Psychiatry. 2021; 78(7):735-743.

PMID: 33881469 PMC: 8060884. DOI: 10.1001/jamapsychiatry.2021.0336.


The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis.

Taylor S, Grove T, Ellingrod V, Tso I Schizophr Bull. 2019; 45(6):1170-1183.

PMID: 31150555 PMC: 6811817. DOI: 10.1093/schbul/sbz046.


Schizophrenia risk and reproductive success: a Mendelian randomization study.

Lawn R, Sallis H, Taylor A, Wootton R, Davey Smith G, Davies N R Soc Open Sci. 2019; 6(3):181049.

PMID: 31031992 PMC: 6458425. DOI: 10.1098/rsos.181049.


Kraepelin's Crumbling Twin Pillars: Using Biology to Reconstruct Psychiatric Nosology From the Bottom Up.

Aquino J, Ross D Biol Psychiatry. 2017; 82(10):e71-e74.

PMID: 29031920 PMC: 5714270. DOI: 10.1016/j.biopsych.2017.09.008.